Marko Babjuk Selected Research

Urologic Neoplasms (Urological Cancer)

1/2021	European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update.
1/2018	European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update.
11/2015	European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update.
6/2013	European guidelines on upper tract urothelial carcinomas: 2013 update.
4/2011	European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marko Babjuk Research Topics

Disease

26	Urinary Bladder Neoplasms (Bladder Cancer) 12/2021 - 10/2005
25	Carcinoma (Carcinomatosis) 03/2022 - 03/2007
22	Neoplasms (Cancer) 01/2021 - 01/2003
17	Non-Muscle Invasive Bladder Neoplasms 08/2022 - 04/2010
5	Urologic Neoplasms (Urological Cancer) 01/2021 - 04/2011
5	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 04/2013
4	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 06/2013
3	Carcinoma in Situ 01/2021 - 04/2010
3	Margins of Excision 02/2016 - 01/2013
2	Lymphatic Metastasis 02/2016 - 01/2013
2	Residual Neoplasm 10/2013 - 04/2010
2	Neoplasm Metastasis (Metastasis) 01/2013 - 12/2012
2	Transitional Cell Carcinoma 04/2011 - 10/2005
1	COVID-19 10/2021
1	Tuberculosis (Tuberculoses) 10/2021
1	Urethral Neoplasms (Urethral Cancer) 01/2018
1	Kidney Neoplasms (Kidney Cancer) 03/2015
1	Disease Progression 10/2014
1	Paraganglioma (Paragangliomas) 01/2003

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 08/2022 - 12/2005
2	Prostate-Specific Antigen (Semenogelase)IBA 02/2020 - 10/2014
2	Gemcitabine FDA Link 01/2020 - 01/2019
2	AcidsIBA 10/2013 - 10/2005
2	5-aminolevulinic acid hexyl ester FDA Link 10/2013 - 04/2010
2	Messenger RNA (mRNA)IBA 03/2007 - 03/2007
1	VaccinesIBA 10/2021
1	AlbuminsIBA 01/2021
1	Protein Isoforms (Isoforms)IBA 01/2021
1	GlobulinsIBA 01/2021
1	Serum AlbuminIBA 01/2021
1	Urokinase Plasminogen Activator ReceptorsIBA 10/2020
1	Plasminogen Activators (Plasminogen Activator)IBA 10/2020
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 10/2020
1	Docetaxel (Taxotere)FDA Link 01/2020
1	Biological ProductsIBA 03/2017
1	Dihydrotachysterol (AT 10)IBA 01/2016
1	Receptor for Advanced Glycation End ProductsIBA 03/2015
1	Lactoylglutathione LyaseIBA 03/2015
1	LigandsIBA 03/2015
1	Matrix Metalloproteinases (MMPs)IBA 11/2007
1	Complementary DNA (cDNA)IBA 10/2006
1	N-acetyltalosaminuronic acid (NAT)IBA 10/2006
1	Tumor Biomarkers (Tumor Markers)IBA 12/2005
1	neuromelaninIBA 01/2003
1	LipofuscinIBA 01/2003
1	Melanins (Melanin)IBA 01/2003

Therapy/Procedure

16	Cystectomy 03/2022 - 08/2012
12	Drug Therapy (Chemotherapy) 01/2022 - 04/2011
10	Nephroureterectomy 01/2021 - 04/2011
7	Transurethral Resection of Bladder 01/2021 - 10/2013
7	Therapeutics 01/2020 - 12/2012
6	Immunotherapy 10/2021 - 12/2012
4	Prostatectomy (Retropubic Prostatectomy) 10/2020 - 04/2013
4	Neoadjuvant Therapy 03/2017 - 04/2011
4	Adjuvant Chemotherapy 02/2016 - 10/2012
3	Radiotherapy 02/2020 - 09/2015
3	Lymph Node Excision (Lymph Node Dissection) 01/2019 - 12/2012
2	Intravesical Administration 01/2019 - 05/2014
2	Lasers (Laser) 12/2015 - 03/2007
1	Induced Hyperthermia (Thermotherapy) 01/2022
1	Operative Surgical Procedures 01/2019
1	Salvage Therapy 01/2018
1	Adjuvant Radiotherapy 10/2014